Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR

Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR

A strong association of pCR (pathological complete response) with disease-free survival or overall survival is clinically desirable. The association of pCR with disease-free survival or overall survival in ER+/HER2−breast cancers following neoadjuvant systemic therapy (NAT) or neoadjuvant endocrine...

Full description

Bibliographic Details
Main Authors: Nandini Dey, Jennifer Aske, Pradip De
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cancers
Subjects:
breast cancer
ER+
neoadjuvant
cell cycle
apoptosis
Online Access:https://www.mdpi.com/2072-6694/13/3/458

Similar Items

Similar Items